Anthera Pharmaceuticals Provides Business Update and Reports 2016 Second Quarter Financial Results

Go back to Anthera Pharmaceuticals Provides Business Update and Reports 2016 Second Quarter Financial Results

Anthera Pharma (ANTH) Misses Q2 EPS by 4c

August 9, 2016 8:36 AM EDT

Anthera Pharma (NASDAQ: ANTH) reported Q2 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.

... More